Francesca Cristofoli
Research Subjects
Francesca Cristofoli has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Macchia
MAGI’S LAB, Rovereto
1 shared publication - Ami Singer
Pediatrics and Medical Genetics, Barzilai Medical Center, 78306, Ashkelon, Israel
1 shared publication - Andrea Bernini
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
1 shared publication - Antonella Mendola
Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 57, 1200 Brussels, Belgium
1 shared publication - Benedetto Falsini
Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
1 shared publication - Dominika Vešelényiová
Department of Biology, Institute of Biology and Biotechnology, Faculty of Natural Sciences, University of Ss. Cyril and Methodius in Trnava, Trnava, Slovakia
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-12
Mathematical Model to Assess Mutational Burden in Retinal Dystrophy Patients Negative to Mendelian Genetic Tests and Carriers of Multiple Recessive Variants
Purpose: Despite advancements in genetic testing, a significant number of patients with retinal dystrophy receive negative test results due to single-allele mutations in genes with autosomal recessive inheritance patterns. This study aimed to address this diagnostic challenge by proposing a preliminary mathematical model based on mutational burden analysis. This approach can identify unique digenic or oligogenic combinations, potentially prioritizing them for further investigation. Methods: We retrospectively analyzed clinical and genetic data from 527 subjects comprising 453 patients with retinal dystrophies (cases) and 74 controls and created semi-synthetic datasets. Protein– protein interaction networks were analyzed, and the significance of mutational burden in specific molecular pathways was investigated. Results: Our model identified two metabolic pathways that are highly correlated to each other, namely “retinoid cycle disease events” and “canonical retinoid cycle in rods (twilight vision).” These pathways were significantly impacted by the burden of variants we found in the case group. Moreover, the gene combinations (ABCA4, RDH12) and (ABCA4, RBP3) were identified exclusively in cases of retinal dystrophies. Conclusion: The proposed preliminary model provides a systematic approach to calculate the mutational burden in patients with retinal dystrophies and previous negative genetic test results. Moreover, the bioinformatic analysis facilitated the identification of recurrent combinations of involved genes, suggesting possible new digenic or oligogenic inheritance patterns.
- 26 August 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-12
Open AccessMathematical Model to Assess Mutational Burden in Retinal Dystrophy Patients Negative to Mendelian Genetic Tests and Carriers of Multiple Recessive Variants
Purpose: Despite advancements in genetic testing, a significant number of patients with retinal dystrophy receive negative test results due to single-allele mutations in genes with autosomal recessive inheritance patterns. This study aimed to address this diagnostic challenge by proposing a preliminary mathematical model based on mutational burden analysis. This approach can identify unique digenic or oligogenic combinations, potentially prioritizing them for further investigation. Methods: We retrospectively analyzed clinical and genetic data from 527 subjects comprising 453 patients with retinal dystrophies (cases) and 74 controls and created semi-synthetic datasets. Protein– protein interaction networks were analyzed, and the significance of mutational burden in specific molecular pathways was investigated. Results: Our model identified two metabolic pathways that are highly correlated to each other, namely “retinoid cycle disease events” and “canonical retinoid cycle in rods (twilight vision).” These pathways were significantly impacted by the burden of variants we found in the case group. Moreover, the gene combinations (ABCA4, RDH12) and (ABCA4, RBP3) were identified exclusively in cases of retinal dystrophies. Conclusion: The proposed preliminary model provides a systematic approach to calculate the mutational burden in patients with retinal dystrophies and previous negative genetic test results. Moreover, the bioinformatic analysis facilitated the identification of recurrent combinations of involved genes, suggesting possible new digenic or oligogenic inheritance patterns.
- 24 April 2018
- Published by Wiley in Human Mutation
- Vol. 39 (7) , 993-1001
NovelCASKmutations in cases with syndromic microcephaly
Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome. Nevertheless, predicting pathogenicity and phenotypic consequences of novel CASK mutations through the exclusive consideration of genetic information and population-based data remains a challenge. Using whole exome sequencing, we identified four novel CASK mutations in individuals with syndromic MC. To understand the functional consequences of the different point mutations on the development of MC and cerebellar defects, we established a transient loss-of-function zebrafish model, and demonstrate recapitulation of relevant neuroanatomical phenotypes. Furthermore, we utilized in vivo complementation studies to demonstrate that the three point mutations confer a loss-of-function effect. This work endorses zebrafish as a tractable model to rapidly assess the effect of novel CASK variants on brain development.
- 24 April 2018
- Published by Wiley in Human Mutation
- Vol. 39 (7) , 993-1001
NovelCASKmutations in cases with syndromic microcephaly
Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome. Nevertheless, predicting pathogenicity and phenotypic consequences of novel CASK mutations through the exclusive consideration of genetic information and population-based data remains a challenge. Using whole exome sequencing, we identified four novel CASK mutations in individuals with syndromic MC. To understand the functional consequences of the different point mutations on the development of MC and cerebellar defects, we established a transient loss-of-function zebrafish model, and demonstrate recapitulation of relevant neuroanatomical phenotypes. Furthermore, we utilized in vivo complementation studies to demonstrate that the three point mutations confer a loss-of-function effect. This work endorses zebrafish as a tractable model to rapidly assess the effect of novel CASK variants on brain development.
- Open Access
- 2 May 2015
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 10 (1) , 1-11
No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR) is a rare autosomal dominant disorder with variable expressivity. It is characterized by mild-to-severe microcephaly, often associated with intellectual disability, ocular defects and lymphedema. It can be sporadic or inherited. Eighty-seven patients have been described to carry a mutation in KIF11, which encodes a homotetrameric motor kinesin, EG5. We tested 23 unreported MCLMR index patients for KIF11. We also reviewed the clinical phenotypes of all our patients as well as of those described in previously published studies. We identified 14 mutations, 12 of which are novel. We detected mutations in 12 affected individuals, from 6 out of 6 familial cases, and in 8 out of 17 sporadic patients. Phenotypic evaluation of patients (our 26 + 61 earlier published = 87) revealed microcephaly in 91%, eye anomalies in 72%, intellectual disability in 67% and lymphedema in 47% of the patients. Unaffected carriers were rare (4 out of 87: 5%). Family history is not a requisite for diagnosis; 31% (16 out of 52) were de novo cases. All inherited cases, and 50% of sporadic cases of MCLMR are due to germline KIF11 mutations. It is possible that mosaic KIF11 mutations cause the remainder of sporadic cases, which the methods employed here were not designed to detect. On the other hand, some of them might have another mimicking disorder and genetic defect, as microcephaly is highly heterogeneous. In aggregate, KIF11 mutations likely cause the majority, if not all, of MCLMR.
- 2 May 2015
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 10 (1) , 1-11
Open AccessNo evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR) is a rare autosomal dominant disorder with variable expressivity. It is characterized by mild-to-severe microcephaly, often associated with intellectual disability, ocular defects and lymphedema. It can be sporadic or inherited. Eighty-seven patients have been described to carry a mutation in KIF11, which encodes a homotetrameric motor kinesin, EG5. We tested 23 unreported MCLMR index patients for KIF11. We also reviewed the clinical phenotypes of all our patients as well as of those described in previously published studies. We identified 14 mutations, 12 of which are novel. We detected mutations in 12 affected individuals, from 6 out of 6 familial cases, and in 8 out of 17 sporadic patients. Phenotypic evaluation of patients (our 26 + 61 earlier published = 87) revealed microcephaly in 91%, eye anomalies in 72%, intellectual disability in 67% and lymphedema in 47% of the patients. Unaffected carriers were rare (4 out of 87: 5%). Family history is not a requisite for diagnosis; 31% (16 out of 52) were de novo cases. All inherited cases, and 50% of sporadic cases of MCLMR are due to germline KIF11 mutations. It is possible that mosaic KIF11 mutations cause the remainder of sporadic cases, which the methods employed here were not designed to detect. On the other hand, some of them might have another mimicking disorder and genetic defect, as microcephaly is highly heterogeneous. In aggregate, KIF11 mutations likely cause the majority, if not all, of MCLMR.